Large-scale testing (Phase 3)Looking for participantsNCT06514612
What this trial is testing
LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired Blepharoptosis.
Who this might be right for
Acquired Blepharophimosis
Santen SAS 234